Thursday, July 9, 2026

pharma · NRXP

NRX Pharmaceuticals

NRX Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

WILMINGTON, DE, USA HQ
Public company Type
NRXP · NYSE Ticker
Company details
Status
Public
HQ
WILMINGTON, DE, USA
Programs
0
Drugs
0
Patents
1
Intelligence · Drug Pipeline

NRX Pharmaceuticals pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

NRX Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →